Neil Maclean

Neil Maclean

UNVERIFIED PROFILE

Are you Neil Maclean?   Register this Author

Register author
Neil Maclean

Neil Maclean

Publications by authors named "Neil Maclean"

Are you Neil Maclean?   Register this Author

31Publications

778Reads

15Profile Views

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.

Cancer Cell 2019 05 2;35(5):721-737.e9. Epub 2019 May 2.

The University of Texas MD Anderson Cancer Center, Molecular Hematology and Therapy, Department of Leukemia, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center; Department of Leukemia, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.03.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620028PMC
May 2019

Characterizing the mitochondrial DNA polymerase gamma interactome by BioID identifies Ruvbl2 localizes to the mitochondria.

Mitochondrion 2017 Jan 11;32:31-35. Epub 2016 Nov 11.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mito.2016.11.001DOI Listing
January 2017

Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells.

Apoptosis 2015 Aug;20(8):1099-108

Princess Margaret Cancer Centre, Ontario Cancer Institute, 610 University Ave, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-015-1137-xDOI Listing
August 2015

2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.

Bioorg Med Chem Lett 2004 Sep;14(18):4697-9

Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.06.085DOI Listing
September 2004

3-(2-pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT(1B/1D) ligands.

Bioorg Med Chem Lett 2004 Feb;14(3):727-9

NPS Pharmaceuticals Inc, 6850 Goreway Dr, Mississauga, Ontario, Canada L4V 1V7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2003.11.023DOI Listing
February 2004

(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands.

Bioorg Med Chem Lett 2003 Oct;13(20):3419-21

NPS Pharmaceuticals Inc., 6850 Goreway Dr., Mississauga, Ontario, Canada L4V 1V7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00779-0DOI Listing
October 2003